Cetera Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$799K Buy
3,659
+2,050
+127% +$452K 0.01% 1278
2023
Q4
$366K Buy
+1,609
New +$338K 0.01% 1305
2023
Q1
Sell
-1,945
Closed -$393K 1691
2022
Q4
$393K Buy
+1,945
New +$380K 0.01% 1096
2016
Q4
Sell
-3,757
Closed -$448K 772
2016
Q3
$448K Buy
3,757
+333
+10% +$39.2K 0.03% 444
2016
Q2
$386K Buy
+3,424
New +$368K 0.03% 496

Other funds holding LH

Cetera Advisors's LH Position: Q1 2024 in Review

Cetera Advisors increased its Labcorp (LH) stake by 127% in Q1 2024, buying an estimated $452K and bringing the position to 3,659 shares worth $799K. The position accounts for 0.01% of the portfolio, ranked #1278.

Cetera Advisors first reported a position in LH in Q2 2016 and has held it in 5 quarters since. 927 funds tracked by Wall St. Rank hold LH as of Q1 2024.

  • Cetera Advisors held 3,659 shares of Labcorp worth $799K as of Q1 2024.
  • Cetera Advisors bought 2,050 Labcorp shares in Q1 2024, an estimated $452K.
  • Labcorp made up 0.01% of Cetera Advisors's portfolio in Q1 2024, its #1278 holding.
  • Cetera Advisors first reported a position in Labcorp in Q2 2016 and has held it in 5 quarters since.
  • 927 funds tracked by Wall St. Rank held Labcorp as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.